Global Sustained Release Ocular Drug Delivery Systems Market Professional Survey Report 2017

December 2017 | 118 pages | ID: GA71E957AFDEN
QYResearch

Abstracts

This report studies Sustained Release Ocular Drug Delivery Systems in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• pSivida
• Allergan
• Icon Bioscience
• Ocular Therapeutix
• Neurotech Pharmaceuticals
• Santen Pharmaceutical
• Aciont Inc.
• Envisia Therapeutics
• GrayBug
• Innocore Pharmaceuticals
• OHR Pharmaceuticals
• PolyActiva
• TheraKine

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Liposome
• Microcapsules/Nanocapsules
• Microspheres/Nanosptheres
• Implants

By Application, the market can be split into

• Cataract
• Glaucoma
• Corneal Transplantation
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Sustained Release Ocular Drug Delivery Systems Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS

1.1 Definition and Specifications of Sustained Release Ocular Drug Delivery Systems
  1.1.1 Definition of Sustained Release Ocular Drug Delivery Systems
  1.1.2 Specifications of Sustained Release Ocular Drug Delivery Systems
1.2 Classification of Sustained Release Ocular Drug Delivery Systems
  1.2.1 Liposome
  1.2.2 Microcapsules/Nanocapsules
  1.2.3 Microspheres/Nanosptheres
  1.2.4 Implants
1.3 Applications of Sustained Release Ocular Drug Delivery Systems
  1.3.1 Cataract
  1.3.2 Glaucoma
  1.3.3 Corneal Transplantation
  1.3.4 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Sustained Release Ocular Drug Delivery Systems
2.3 Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems
2.4 Industry Chain Structure of Sustained Release Ocular Drug Delivery Systems

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS

3.1 Capacity and Commercial Production Date of Global Sustained Release Ocular Drug Delivery Systems Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Sustained Release Ocular Drug Delivery Systems Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Sustained Release Ocular Drug Delivery Systems Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Sustained Release Ocular Drug Delivery Systems Major Manufacturers in 2016

4 GLOBAL SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Sustained Release Ocular Drug Delivery Systems Capacity and Growth Rate Analysis
  4.2.2 2016 Sustained Release Ocular Drug Delivery Systems Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate Analysis
  4.3.2 2016 Sustained Release Ocular Drug Delivery Systems Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Sustained Release Ocular Drug Delivery Systems Sales Price
  4.4.2 2016 Sustained Release Ocular Drug Delivery Systems Sales Price Analysis (Company Segment)

5 SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS REGIONAL MARKET ANALYSIS

5.1 North America Sustained Release Ocular Drug Delivery Systems Market Analysis
  5.1.1 North America Sustained Release Ocular Drug Delivery Systems Market Overview
  5.1.2 North America 2012-2017E Sustained Release Ocular Drug Delivery Systems Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales Price Analysis
  5.1.4 North America 2016 Sustained Release Ocular Drug Delivery Systems Market Share Analysis
5.2 China Sustained Release Ocular Drug Delivery Systems Market Analysis
  5.2.1 China Sustained Release Ocular Drug Delivery Systems Market Overview
  5.2.2 China 2012-2017E Sustained Release Ocular Drug Delivery Systems Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales Price Analysis
  5.2.4 China 2016 Sustained Release Ocular Drug Delivery Systems Market Share Analysis
5.3 Europe Sustained Release Ocular Drug Delivery Systems Market Analysis
  5.3.1 Europe Sustained Release Ocular Drug Delivery Systems Market Overview
  5.3.2 Europe 2012-2017E Sustained Release Ocular Drug Delivery Systems Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales Price Analysis
  5.3.4 Europe 2016 Sustained Release Ocular Drug Delivery Systems Market Share Analysis
5.4 Southeast Asia Sustained Release Ocular Drug Delivery Systems Market Analysis
  5.4.1 Southeast Asia Sustained Release Ocular Drug Delivery Systems Market Overview
  5.4.2 Southeast Asia 2012-2017E Sustained Release Ocular Drug Delivery Systems Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales Price Analysis
  5.4.4 Southeast Asia 2016 Sustained Release Ocular Drug Delivery Systems Market Share Analysis
5.5 Japan Sustained Release Ocular Drug Delivery Systems Market Analysis
  5.5.1 Japan Sustained Release Ocular Drug Delivery Systems Market Overview
  5.5.2 Japan 2012-2017E Sustained Release Ocular Drug Delivery Systems Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales Price Analysis
  5.5.4 Japan 2016 Sustained Release Ocular Drug Delivery Systems Market Share Analysis
5.6 India Sustained Release Ocular Drug Delivery Systems Market Analysis
  5.6.1 India Sustained Release Ocular Drug Delivery Systems Market Overview
  5.6.2 India 2012-2017E Sustained Release Ocular Drug Delivery Systems Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales Price Analysis
  5.6.4 India 2016 Sustained Release Ocular Drug Delivery Systems Market Share Analysis

6 GLOBAL 2012-2017E SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales by Type
6.2 Different Types of Sustained Release Ocular Drug Delivery Systems Product Interview Price Analysis
6.3 Different Types of Sustained Release Ocular Drug Delivery Systems Product Driving Factors Analysis
  6.3.1 Liposome of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis
  6.3.2 Microcapsules/Nanocapsules of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis
  6.3.3 Microspheres/Nanosptheres of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis
  6.3.4 Implants of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis

7 GLOBAL 2012-2017E SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Sustained Release Ocular Drug Delivery Systems Consumption by Application
7.2 Different Application of Sustained Release Ocular Drug Delivery Systems Product Interview Price Analysis
7.3 Different Application of Sustained Release Ocular Drug Delivery Systems Product Driving Factors Analysis
  7.3.1 Cataract of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis
  7.3.2 Glaucoma of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis
  7.3.3 Corneal Transplantation of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis
  7.3.4 Others of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS

8.1 pSivida
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 pSivida 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 pSivida 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
8.2 Allergan
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Allergan 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Allergan 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
8.3 Icon Bioscience
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Icon Bioscience 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Icon Bioscience 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
8.4 Ocular Therapeutix
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Ocular Therapeutix 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Ocular Therapeutix 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
8.5 Neurotech Pharmaceuticals
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Neurotech Pharmaceuticals 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Neurotech Pharmaceuticals 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
8.6 Santen Pharmaceutical
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Santen Pharmaceutical 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Santen Pharmaceutical 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
8.7 Aciont Inc.
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Aciont Inc. 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Aciont Inc. 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
8.8 Envisia Therapeutics
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Envisia Therapeutics 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Envisia Therapeutics 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
8.9 GrayBug
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 GrayBug 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 GrayBug 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
8.10 Innocore Pharmaceuticals
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Innocore Pharmaceuticals 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Innocore Pharmaceuticals 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
8.11 OHR Pharmaceuticals
8.12 PolyActiva
8.13 TheraKine

9 DEVELOPMENT TREND OF ANALYSIS OF SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS MARKET

9.1 Global Sustained Release Ocular Drug Delivery Systems Market Trend Analysis
  9.1.1 Global 2017-2022 Sustained Release Ocular Drug Delivery Systems Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Sustained Release Ocular Drug Delivery Systems Sales Price Forecast
9.2 Sustained Release Ocular Drug Delivery Systems Regional Market Trend
  9.2.1 North America 2017-2022 Sustained Release Ocular Drug Delivery Systems Consumption Forecast
  9.2.2 China 2017-2022 Sustained Release Ocular Drug Delivery Systems Consumption Forecast
  9.2.3 Europe 2017-2022 Sustained Release Ocular Drug Delivery Systems Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Sustained Release Ocular Drug Delivery Systems Consumption Forecast
  9.2.5 Japan 2017-2022 Sustained Release Ocular Drug Delivery Systems Consumption Forecast
  9.2.6 India 2017-2022 Sustained Release Ocular Drug Delivery Systems Consumption Forecast
9.3 Sustained Release Ocular Drug Delivery Systems Market Trend (Product Type)
9.4 Sustained Release Ocular Drug Delivery Systems Market Trend (Application)

10 SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS MARKETING TYPE ANALYSIS

10.1 Sustained Release Ocular Drug Delivery Systems Regional Marketing Type Analysis
10.2 Sustained Release Ocular Drug Delivery Systems International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Sustained Release Ocular Drug Delivery Systems by Region
10.4 Sustained Release Ocular Drug Delivery Systems Supply Chain Analysis

11 CONSUMERS ANALYSIS OF SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Sustained Release Ocular Drug Delivery Systems
Table Product Specifications of Sustained Release Ocular Drug Delivery Systems
Table Classification of Sustained Release Ocular Drug Delivery Systems
Figure Global Production Market Share of Sustained Release Ocular Drug Delivery Systems by Type in 2016
Figure Liposome Picture
Table Major Manufacturers of Liposome
Figure Microcapsules/Nanocapsules Picture
Table Major Manufacturers of Microcapsules/Nanocapsules
Figure Microspheres/Nanosptheres Picture
Table Major Manufacturers of Microspheres/Nanosptheres
Figure Implants Picture
Table Major Manufacturers of Implants
Table Applications of Sustained Release Ocular Drug Delivery Systems
Figure Global Consumption Volume Market Share of Sustained Release Ocular Drug Delivery Systems by Application in 2016
Figure Cataract Examples
Table Major Consumers in Cataract
Figure Glaucoma Examples
Table Major Consumers in Glaucoma
Figure Corneal Transplantation Examples
Table Major Consumers in Corneal Transplantation
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Sustained Release Ocular Drug Delivery Systems by Regions
Figure North America Sustained Release Ocular Drug Delivery Systems Market Size (Million USD) (2012-2022)
Figure China Sustained Release Ocular Drug Delivery Systems Market Size (Million USD) (2012-2022)
Figure Europe Sustained Release Ocular Drug Delivery Systems Market Size (Million USD) (2012-2022)
Figure Southeast Asia Sustained Release Ocular Drug Delivery Systems Market Size (Million USD) (2012-2022)
Figure Japan Sustained Release Ocular Drug Delivery Systems Market Size (Million USD) (2012-2022)
Figure India Sustained Release Ocular Drug Delivery Systems Market Size (Million USD) (2012-2022)
Table Sustained Release Ocular Drug Delivery Systems Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Sustained Release Ocular Drug Delivery Systems in 2016
Figure Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems
Figure Industry Chain Structure of Sustained Release Ocular Drug Delivery Systems
Table Capacity and Commercial Production Date of Global Sustained Release Ocular Drug Delivery Systems Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Sustained Release Ocular Drug Delivery Systems Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Sustained Release Ocular Drug Delivery Systems Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Sustained Release Ocular Drug Delivery Systems Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Sustained Release Ocular Drug Delivery Systems 2012-2017
Figure Global 2012-2017E Sustained Release Ocular Drug Delivery Systems Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Sustained Release Ocular Drug Delivery Systems Market Size (Value) and Growth Rate
Table 2012-2017E Global Sustained Release Ocular Drug Delivery Systems Capacity and Growth Rate
Table 2016 Global Sustained Release Ocular Drug Delivery Systems Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate
Table 2016 Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs)
Table 2016 Global Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Sustained Release Ocular Drug Delivery Systems 2012-2017E
Figure North America 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs)
Figure North America 2016 Sustained Release Ocular Drug Delivery Systems Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Sustained Release Ocular Drug Delivery Systems 2012-2017E
Figure China 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs)
Figure China 2016 Sustained Release Ocular Drug Delivery Systems Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Sustained Release Ocular Drug Delivery Systems 2012-2017E
Figure Europe 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs)
Figure Europe 2016 Sustained Release Ocular Drug Delivery Systems Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Sustained Release Ocular Drug Delivery Systems 2012-2017E
Figure Southeast Asia 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Sustained Release Ocular Drug Delivery Systems Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Sustained Release Ocular Drug Delivery Systems 2012-2017E
Figure Japan 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs)
Figure Japan 2016 Sustained Release Ocular Drug Delivery Systems Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Sustained Release Ocular Drug Delivery Systems 2012-2017E
Figure India 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs)
Figure India 2016 Sustained Release Ocular Drug Delivery Systems Sales Market Share
Table Global 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type
Table Different Types Sustained Release Ocular Drug Delivery Systems Product Interview Price
Table Global 2012-2017E Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application
Table Different Application Sustained Release Ocular Drug Delivery Systems Product Interview Price
Table pSivida Information List
Table Product A Overview
Table Product B Overview
Table 2016 pSivida Sustained Release Ocular Drug Delivery Systems Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 pSivida Sustained Release Ocular Drug Delivery Systems Business Region Distribution
Table Allergan Information List
Table Product A Overview
Table Product B Overview
Table 2016 Allergan Sustained Release Ocular Drug Delivery Systems Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Allergan Sustained Release Ocular Drug Delivery Systems Business Region Distribution
Table Icon Bioscience Information List
Table Product A Overview
Table Product B Overview
Table 2015 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Business Region Distribution
Table Ocular Therapeutix Information List
Table Product A Overview
Table Product B Overview
Table 2016 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Business Region Distribution
Table Neurotech Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Business Region Distribution
Table Santen Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2016 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Business Region Distribution
Table Aciont Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Business Region Distribution
Table Envisia Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2016 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Business Region Distribution
Table GrayBug Information List
Table Product A Overview
Table Product B Overview
Table 2016 GrayBug Sustained Release Ocular Drug Delivery Systems Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 GrayBug Sustained Release Ocular Drug Delivery Systems Business Region Distribution
Table Innocore Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Business Region Distribution
Table OHR Pharmaceuticals Information List
Table PolyActiva Information List
Table TheraKine Information List
Figure Global 2017-2022 Sustained Release Ocular Drug Delivery Systems Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Sustained Release Ocular Drug Delivery Systems Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Sustained Release Ocular Drug Delivery Systems Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Sustained Release Ocular Drug Delivery Systems Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Sustained Release Ocular Drug Delivery Systems Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Sustained Release Ocular Drug Delivery Systems Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Sustained Release Ocular Drug Delivery Systems Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Sustained Release Ocular Drug Delivery Systems Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Sustained Release Ocular Drug Delivery Systems by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Sustained Release Ocular Drug Delivery Systems by Application 2017-2022
Table Traders or Distributors with Contact Information of Sustained Release Ocular Drug Delivery Systems by Region